ArticleJournal of clinical medicine2024

Efficacy and Safety in a Real-World Study of the New Oral Formulation of Semaglutide in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus.

María Marques Vidas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.